167 related articles for article (PubMed ID: 15141037)
1. Pharmacological and genetic modulation of Wnt-targeted Cre-Lox-mediated gene expression in colorectal cancer cells.
Bordonaro M; Lazarova DL; Sartorelli AC
Nucleic Acids Res; 2004; 32(8):2660-74. PubMed ID: 15141037
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Wnt-specific colon cancer cell kill by butyrate and lithium.
Bordonaro M; Lazarova DL; Carbone R; Sartorelli AC
Oncol Res; 2004; 14(9):427-38. PubMed ID: 15490974
[TBL] [Abstract][Full Text] [Related]
3. Cell type- and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate.
Bordonaro M; Lazarova DL; Augenlicht LH; Sartorelli AC
Int J Cancer; 2002 Jan; 97(1):42-51. PubMed ID: 11774242
[TBL] [Abstract][Full Text] [Related]
4. Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate.
Lazarova DL; Bordonaro M; Carbone R; Sartorelli AC
Int J Cancer; 2004 Jul; 110(4):523-31. PubMed ID: 15122584
[TBL] [Abstract][Full Text] [Related]
5. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
[TBL] [Abstract][Full Text] [Related]
6. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
7. Butyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells.
Lazarova DL; Chiaro C; Bordonaro M
BMC Res Notes; 2014 Apr; 7():226. PubMed ID: 24716727
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
9. Induction of cre recombinase activity using modified androgen receptor ligand binding domains: a sensitive assay for ligand-receptor interactions.
Kaczmarczyk SJ; Green JE
Nucleic Acids Res; 2003 Aug; 31(15):e86. PubMed ID: 12888538
[TBL] [Abstract][Full Text] [Related]
10. The Cre-loxP recombination-based reporter system for plant transcriptional expression studies.
Shigaki T; Vyzasatya RR; Sivitz AB; Ward JM; Sze H; Hirschi KD
Plant Mol Biol; 2005 May; 58(1):65-73. PubMed ID: 16028117
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific Cre-mediated activation of the diphtheria toxin gene in pituitary tumor cells: potential for cytotoxic gene therapy.
Lee EJ; Jameson JL
Hum Gene Ther; 2002 Mar; 13(4):533-42. PubMed ID: 11874631
[TBL] [Abstract][Full Text] [Related]
12. Modular Cre/lox system and genetic therapeutics for colorectal cancer.
Bordonaro M
J Biomed Biotechnol; 2009; 2009():358230. PubMed ID: 19809520
[TBL] [Abstract][Full Text] [Related]
13. Optimization of a synthetic beta-catenin-dependent promoter for tumor-specific cancer gene therapy.
Lipinski KS; Djeha HA; Gawn J; Cliffe S; Maitland NJ; Palmer DH; Mountain A; Irvine AS; Wrighton CJ
Mol Ther; 2004 Jul; 10(1):150-61. PubMed ID: 15233950
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
15. Lineage-specific cell disruption in living mice by Cre-mediated expression of diphtheria toxin A chain.
Matsumura H; Hasuwa H; Inoue N; Ikawa M; Okabe M
Biochem Biophys Res Commun; 2004 Aug; 321(2):275-9. PubMed ID: 15358172
[TBL] [Abstract][Full Text] [Related]
16. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.
van de Wetering M; Barker N; Harkes IC; van der Heyden M; Dijk NJ; Hollestelle A; Klijn JG; Clevers H; Schutte M
Cancer Res; 2001 Jan; 61(1):278-84. PubMed ID: 11196175
[TBL] [Abstract][Full Text] [Related]
17. LEF/TCF-dependent, fluorescence-based reporter gene assay for Wnt signaling.
Sussman DJ
Biotechniques; 2002 May; 32(5):1000, 1002. PubMed ID: 12019770
[No Abstract] [Full Text] [Related]
18. Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.
Dihlmann S; Kloor M; Fallsehr C; von Knebel Doeberitz M
Carcinogenesis; 2005 Sep; 26(9):1503-12. PubMed ID: 15888491
[TBL] [Abstract][Full Text] [Related]
19. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter.
Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M
Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444
[TBL] [Abstract][Full Text] [Related]
20. Cell depletion due to diphtheria toxin fragment A after Cre-mediated recombination.
Brockschnieder D; Lappe-Siefke C; Goebbels S; Boesl MR; Nave KA; Riethmacher D
Mol Cell Biol; 2004 Sep; 24(17):7636-42. PubMed ID: 15314171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
